Literature DB >> 15293276

PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis.

Masako Bilak1, Liejun Wu, Qian Wang, Norman Haughey, Katherine Conant, Coryse St Hillaire, Katrin Andreasson.   

Abstract

Recent studies suggest that the inducible isoform of cyclooxygenase, COX-2, promotes motor neuron loss in rodent models of ALS. We investigated the effects of PGE2, a principal downstream prostaglandin product of COX-2 activity, on motor neuron survival in an organotypic culture model of ALS. We find that PGE2 paradoxically protects motor neurons at physiological concentrations in this model. PGE2 exerts its downstream effects by signaling through a class of four distinct G-protein-coupled E-prostanoid receptors (EP1-EP4) that have divergent effects on cAMP. EP2 and EP3 are dominantly expressed in ventral spinal cord in neurons and astrocytes, and activation of these receptor subtypes individually or in combination also rescued motor neurons. The EP2 receptor is positively coupled to cAMP, and its neuroprotection was mimicked by application of forskolin and blocked by inhibition of PKA, suggesting that its protective effect is mediated by downstream effects of cAMP. Conversely, the EP3 receptor is negatively coupled to cAMP, and its neuroprotective effect was blocked by pertussis toxin, suggesting that its protective effect is dependent on Gi-coupled heterotrimeric signaling. Taken together, these data demonstrate an unexpected neuroprotective effect mediated by PGE2, in which activation of its EP2 and EP3 receptors protected motor neurons from chronic glutamate toxicity. Copyright 2004 American Neurological Association

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293276     DOI: 10.1002/ana.20179

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  46 in total

1.  Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy.

Authors:  Hidetoshi Taniguchi; Christoph Anacker; Gabriela Beatriz Suarez-Mier; Qian Wang; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2011-09-12       Impact factor: 3.046

Review 2.  Molecular and cellular immune mediators of neuroprotection.

Authors:  Nicolas P Turrin; Serge Rivest
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

3.  Activation of EP2 prostanoid receptors in human glial cell lines stimulates the secretion of BDNF.

Authors:  Anthony J Hutchinson; Chih-Ling Chou; Davelene D Israel; Wei Xu; John W Regan
Journal:  Neurochem Int       Date:  2009-02-06       Impact factor: 3.921

Review 4.  Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

Authors:  P J Cimino; C Dirk Keene; Richard M Breyer; Kathleen S Montine; Thomas J Montine
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Prostaglandin receptor EP2 protects dopaminergic neurons against 6-OHDA-mediated low oxidative stress.

Authors:  Emilce Carrasco; Peter Werner; Diana Casper
Journal:  Neurosci Lett       Date:  2008-06-06       Impact factor: 3.046

Review 6.  Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.

Authors:  Dejan Milatovic; Thomas J Montine; Michael Aschner
Journal:  Neurotoxicology       Date:  2011-03-03       Impact factor: 4.294

Review 7.  A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.

Authors:  Asheebo Rojas; Thota Ganesh; Wenyi Wang; Jennifer Wang; Raymond Dingledine
Journal:  Neurobiol Dis       Date:  2019-02-25       Impact factor: 5.996

8.  Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.

Authors:  Juan Andrés Parga; María García-Garrote; Salvador Martínez; Ángel Raya; José Luis Labandeira-García; Jannette Rodríguez-Pallares
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

9.  Divergent effects of prostaglandin receptor signaling on neuronal survival.

Authors:  Liejun Wu; Qian Wang; Xibin Liang; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2007-06-07       Impact factor: 3.046

10.  The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.

Authors:  Xibin Liang; Qian Wang; Ju Shi; Ludmila Lokteva; Richard M Breyer; Thomas J Montine; Katrin Andreasson
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.